According to Vision Research Reports, the global electron beam linear accelerators market size surpassed at US$ 337 Mn in 2020 and is expected to expand at a moderate CAGR from 2021 to 2030.
The global electron beam linear accelerators market size is expected to reach US$ 1.4 billion by 2030. Increase in incidence and prevalence of skin & breast cancer, adoption of electron beam intraoperative radiation therapy (IORT) for treatment of breast cancer, favorable insurance coverage for electron beam linear accelerators, surge in recommendation for electron beam therapy are anticipated to propel the global electron beam linear accelerators market.
Electron beam linear accelerators are innovative particle accelerators, which use high energy X-rays or electrons to locate and conform tumor shape, consequently destroying cancer cells. The global electron beam linear accelerators market is driven by the adoption of innovative electron beam linear accelerators, developments in radiation therapy, ongoing clinical trials, and increase in recommendation of electron beam therapy for cancer treatment. North America dominated the global electron beam linear accelerators market in 2019, followed by Europe and Asia Pacific. North America’s dominance can be ascribed to technological advancements, adoption of radiation therapy, and rise in incidence & prevalence of skin and breast cancers.
Rise in Prevalence of Skin and Breast Cancer to Drive Global Market
Skin cancer is the most common form of cancer. According to the American Cancer Society, melanoma accounts for only about 1% of skin cancers. However, it leads to majority of skin cancer deaths. Around 100,350 new melanoma cases are projected to be diagnosed in the U.S. in 2020; of these, 60,190 will be diagnosed in men and 40,160 in women. According to observations by the American Cancer Society, the number of melanoma cases has been rising rapidly over the last few decades. The World Cancer Research Fund International states that melanoma is the 19th most common type of cancer found in men and women. In 2018, there were about 300,000 new cases across the globe.
The Centers for Disease Control and Prevention (CDC) confirms that breast cancer is the most common in women. In 2017, breast cancer accounted for 30% of all types of newly diagnosed cancers among women. According to the American Cancer Society, nearly 252,710 new cases of cancer were diagnosed in the U.S. in 2017 and the incidence is expected to increase substantially over the next few years. Breastcancer.org highlights that nearly 3.1 million women in the U.S. had a history of breast cancer as of January 2018. The organization stated that nearly 266,120 new cases of invasive breast cancer were diagnosed in the U.S. in 2018.
The prevalence of breast cancer is rising in Europe and Asia Pacific. According to the Cancer Research UK, breast cancer accounted for 15% of newly diagnosed cancer cases in the U.K. Additionally, breast cancer has become a major health concern in Asia Pacific. Therefore, rise in prevalence of skin and breast cancers is projected to boost the electron beam linear accelerators market.
Electron Beam Therapy Overcomes Shortcomings of Megavoltage LINACs in Dermatology
The superficial electron therapy is being highly publicized for the treatment of skin cancer. Since surgery leads to medical contraindications for many patients, manufacturers in the electron beam linear accelerators market are increasing their production capacities for machines. Most patients prefer an active lifestyle and have potential cosmetic concerns pertaining to surgery. This is fueling the demand for electron beam linear accelerators that are non-invasive and convenient.
High cost and complexity of megavoltage LINACs are being overcome with patient accessibility toward the electron beam therapy. Companies in the electron beam linear accelerators market are introducing proprietary technologies to overcome the shortcomings of full scale LINACs. Electron beam LINACs are minimizing the cost of particle therapy, whilst reducing the device footprint. Innovative electron beam LINACs are adapting to a dermatologist’s existing practice workflow.
Improved Testing Capabilities Help Eliminate Issues of Low Emittance Beam Generation
The business of electron beam linear accelerator machines is estimated to reach US$ 1 Bn by the end of 2030. However, equipment manufacturers need to address issues of low emittance beam generation and electron cloud collective instabilities. Manufacturers in the electron beam linear accelerators market can achieve this by increasing their testing capabilities to create availability for quality machines.
Companies in the electron beam linear accelerators market are increasing their focus in remanufacturing and repairing of machines. For instance, Altair— a manufacturer of linear accelerators (LINACs), is offering custom solutions to innovate in electron beam linear accelerators. In order to gain a competitive edge over other manufacturers, companies are delivering turnkey solutions in machines that deploy various energy outputs. Investments in testing and tuning facilities are emerging as a recurring trend of established market players.
Segmentation
Prominent Regions
The global electron beam linear accelerators market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global electron beam linear accelerators market in 2019, followed by Europe and Asia Pacific. Presence of prominent companies operating in the market, recent advancement in radiation therapy, and increase in availability of radiation therapy are factors projected to drive the market in North America. Furthermore, adoption of electron beam linear accelerators coupled with modern comprehensive cancer management of patients at healthcare centers is projected to fuel the growth of the market in the U.S.
The electron beam linear accelerators market in Europe is anticipated to expand at a high CAGR from 2020 to 2030.The market is the region is driven by increase in incidence of skin and breast cancer, surge in expenditure on radiation therapy by hospitals, and rise in number of healthcare centers providing skin cancer diagnosis and treatment services. High quality radiation oncology services for patients in healthcare centers and increase in the number of healthcare centers using the electron beam radiation therapy for the treatment of patients are projected to accelerate the growth of the market during the forecast period in Europe.
Agreements and Merger & Acquisitions among Key Strategies Being Adopted in Global Market
The global electron beam linear accelerators market is consolidated in terms of number of players. The market is dominated by few key players, including Varian Medical Systems, Inc., IntraOp Medical, Inc., and S.I.T. Sordina IORT Technologies S.p.A. Partnerships, contracts, merger & acquisitions, and innovative product approvals boost companies presence in the global electron beam linear accelerators market.
In March 2020, Varian announced that a notice of intent to grant a sole source contract to Varian Medical Systems, Inc. for an order of 12 medical LINACs was filed by the Quebec Government, Groupe d'Approvisionnement Commun de l'Est du Québec (GACEQ). In May 2020, Varian Medical Systems entered into a partnership with the National University Cancer Institute, Singapore (NCIS) to expand access to cancer solutions in Singapore.
Market Segmentation
By Type
By End User
By Region
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Electron Beam Linear Accelerators Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Developments in Radiation Therapy
5.2. Intraoperative Electron Beam Radiation Therapy - Clinics Trials
5.3. Epidemiology of Cancer Globally/ Country
5.4. COVID-19 Pandemic Impact on Global Electron Beam Linear Accelerators Market
6. Global Electron Beam Linear Accelerators Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Electron Beam Linear Accelerators Market Value Forecast, by Type, 2018–2030
6.3.1. Low-energy Machine
6.3.2. High-energy Machine
6.4. Market Attractiveness Analysis, by Type
7. Global Electron Beam Linear Accelerators Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Electron Beam Linear Accelerators Market Value Forecast, by End-user, 2018–2030
7.3.1. Hospitals & Ambulatory Care Centers
7.3.2. Clinics
7.3.3. Academic & Research Centers
7.4. Global Electron Beam Linear Accelerators Market Attractiveness Analysis, by End-user
8. Global Electron Beam Linear Accelerators Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Electron Beam Linear Accelerators Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Electron Beam Linear Accelerators Market Attractiveness Analysis, by Region
9. North America Electron Beam Linear Accelerators Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Electron Beam Linear Accelerators Market Value Forecast, by Type, 2018–2030
9.2.1. Low-energy Machine
9.2.2. High-energy Machine
9.3. North America Electron Beam Linear Accelerators Market Value Forecast, by End-user, 2018–2030
9.3.1. Hospitals & Ambulatory Care Centers
9.3.2. Clinics
9.3.3. Academic & Research Centers
9.4. North America Electron Beam Linear Accelerators Market Value Forecast, by Country, 2018–2030
9.4.1. U.S.
9.4.2. Canada
9.5. North America Electron Beam Linear Accelerators Market Attractiveness Analysis
9.5.1. By Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Electron Beam Linear Accelerators Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Electron Beam Linear Accelerators Market Value Forecast, by Type, 2018–2030
10.2.1. Low-energy Machine
10.2.2. High-energy Machine
10.3. Europe Electron Beam Linear Accelerators Market Value Forecast, by End-user, 2018–2030
10.3.1. Hospitals & Ambulatory Care Centers
10.3.2. Clinics
10.3.3. Academic & Research Centers
10.4. Europe Electron Beam Linear Accelerators Market Value Forecast, by Country/Sub-region, 2018–2030
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Electron Beam Linear Accelerators Market Attractiveness Analysis
10.5.1. By Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Electron Beam Linear Accelerators Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Electron Beam Linear Accelerators Market Value Forecast, by Type, 2018–2030
11.2.1. Low-energy Machine
11.2.2. High-energy Machine
11.3. Asia Pacific Electron Beam Linear Accelerators Market Value Forecast, by End-user, 2018–2030
11.3.1. Hospitals & Ambulatory Care Centers
11.3.2. Clinics
11.3.3. Academic & Research Centers
11.4. Asia Pacific Electron Beam Linear Accelerators Market Value Forecast, by Country/Sub-region, 2018–2030
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Electron Beam Linear Accelerators Market Attractiveness Analysis
11.5.1. By Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Electron Beam Linear Accelerators Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Electron Beam Linear Accelerators Market Value Forecast, by Type, 2018–2030
12.2.1. Low-energy Machine
12.2.2. High-energy Machine
12.3. Latin America Electron Beam Linear Accelerators Market Value Forecast, by End-user, 2018–2030
12.3.1. Hospitals & Ambulatory Care Centers
12.3.2. Clinics
12.3.3. Academic & Research Centers
12.4. Latin America Electron Beam Linear Accelerators Market Value Forecast, by Country/Sub-region, 2018–2030
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Electron Beam Linear Accelerators Market Attractiveness Analysis
12.5.1. By Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Electron Beam Linear Accelerators Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Electron Beam Linear Accelerators Market Value Forecast, by Type, 2018–2030
13.2.1. Low-energy Machine
13.2.2. High-energy Machine
13.3. Middle East & Africa Electron Beam Linear Accelerators Market Value Forecast, by End-user, 2018–2030
13.3.1. Hospitals & Ambulatory Care Centers
13.3.2. Clinics
13.3.3. Academic & Research Centers
13.4. Middle East & Africa Electron Beam Linear Accelerators Market Value Forecast, by Country/Sub-region, 2018–2030
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Electron Beam Linear Accelerators Market Attractiveness Analysis
13.5.1. By Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competitive Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Company Profiles
14.2.1. Varian Medical Systems, Inc.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. Strategic Overview
14.2.1.4. SWOT Analysis
14.2.2. IntraOp Medical, Inc.
14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.2.2. Product Portfolio
14.2.2.3. Strategic Overview
14.2.2.4. SWOT Analysis
14.2.3. S.I.T. Sordina IORT Technologies S.p.A.
14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.3.2. Product Portfolio
14.2.3.3. Strategic Overview
14.2.3.4. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers